Figures & data
Table 1. Baseline characteristics of the patient population.
Figure 1. Kaplan Meier’s survival curve of patients who were restarted on warfarin with normal kidney function (broken line) and chronic kidney disease patients (solid line).
![Figure 1. Kaplan Meier’s survival curve of patients who were restarted on warfarin with normal kidney function (broken line) and chronic kidney disease patients (solid line).](/cms/asset/d69943f7-8949-49ff-a872-a21f3fe60dde/irnf_a_819766_f0001_b.jpg)
Figure 2. Kaplan Meier's survival curve of patients with chronic kidney disease that were restarted on warfarin (broken line) versus chronic kidney disease patients who were not restarted on warfarin (solid line).
![Figure 2. Kaplan Meier's survival curve of patients with chronic kidney disease that were restarted on warfarin (broken line) versus chronic kidney disease patients who were not restarted on warfarin (solid line).](/cms/asset/4c81ad32-d4cd-4c62-bc67-417aa215992d/irnf_a_819766_f0002_b.jpg)
Table 2. Risk of various outcomes in CKD patients.
Figure 3. Kaplan Meier’s survival curve of patients who were restarted on warfarin with normal kidney function (broken line) and end stage renal disease patients on hemodialysis (solid line).
![Figure 3. Kaplan Meier’s survival curve of patients who were restarted on warfarin with normal kidney function (broken line) and end stage renal disease patients on hemodialysis (solid line).](/cms/asset/8e6e84b2-82b3-408c-8ca4-fea5c7fc9b1a/irnf_a_819766_f0003_b.jpg)
Figure 4. Kaplan Meier's survival curve of patients with end stage renal disease patients on hemodialysis that were restarted on warfarin (broken line) versus end stage renal disease patients on hemodialysis that were not restarted on warfarin (solid line).
![Figure 4. Kaplan Meier's survival curve of patients with end stage renal disease patients on hemodialysis that were restarted on warfarin (broken line) versus end stage renal disease patients on hemodialysis that were not restarted on warfarin (solid line).](/cms/asset/6438470f-c9c5-4163-85bd-07df7ee2b98d/irnf_a_819766_f0004_b.jpg)
Table 3. Risk of various outcomes in ESRD patients.